Mucosal Vaccination with a Self-Adjuvanted Lipopeptide Is Immunogenic and Protective against Mycobacterium tuberculosis

被引:21
作者
Ashhurst, Anneliese S. [1 ,2 ]
McDonald, David M. [1 ]
Hanna, Cameron C. [1 ]
Stanojevic, Vicki A. [1 ]
Britton, Warwick J. [2 ,3 ]
Payne, Richard J. [1 ]
机构
[1] Univ Sydney, Sch Chem, Camperdown, NSW 2050, Australia
[2] Univ Sydney, TB Res Program Centenary Inst, Camperdown, NSW 2050, Australia
[3] Univ Sydney, Fac Med & Hlth, Camperdown, NSW 2050, Australia
基金
英国医学研究理事会;
关键词
MULTIDRUG-RESISTANT TUBERCULOSIS; SOLID-PHASE SYNTHESIS; IMMUNOLOGICAL EVALUATION; EPIDEMIC SPREAD; TH17; CELLS; PEPTIDE; VACCINES; BCG; IMMUNIZATION; INFECTION;
D O I
10.1021/acs.jmedchem.9b00832
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tuberculosis (TB) remains a staggering burden on global public health. Novel preventative tools are desperately needed to reach the targets of the WHO post-2015 End-TB Strategy. Peptide or protein-based subunit vaccines offer potential as safe and effective generators of protection, and enhancement of local pulmonary immunity may be achieved by mucosal delivery. We describe the synthesis of a novel subunit vaccine via native chemical ligation. Two immunogenic epitopes, ESAT6(1_20) and TB10.4(3-11) from Mycobacterium tuberculosis (Mtb), were covalently conjugated to the TLR2-ligand Pam(2)Cys to generate a self-adjuvanting lipopeptide vaccine. When administered mucosally to mice, the vaccine enhanced pulmonary immunogenicity, inducing strong Th17 responses in the lungs and multifunctional peripheral T-lymphocytes. Mucosal, but not peripheral vaccination, provided substantial protection against Mtb infection, emphasizing the importance of delivery route for optimal efficacy.
引用
收藏
页码:8080 / 8089
页数:10
相关论文
共 50 条
[1]   The success and failure of BCG - implications for a novel tuberculosis vaccine [J].
Andersen, P ;
Doherty, TM .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (08) :656-662
[2]   Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses [J].
Andersson, Marta ;
Lutay, Nataliya ;
Hallgren, Oscar ;
Westergren-Thorsson, Gunilla ;
Svensson, Majlis ;
Godaly, Gabriela .
INNATE IMMUNITY, 2012, 18 (03) :531-540
[3]   Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid [J].
Cai, Hui ;
Chen, Mei-Sha ;
Sun, Zhan-Yi ;
Zhao, Yu-Fen ;
Kunz, Horst ;
Li, Yan-Mei .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (23) :6106-6110
[4]   Be careful what you ask for: is the presence of IL-17 indicative of immunity? [J].
Cooper, Andrea M. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (02) :221-223
[5]   Alternative routes of measles immunization: a review [J].
Cutts, FT ;
Clements, CJ ;
Bennett, JV .
BIOLOGICALS, 1997, 25 (03) :323-338
[6]   SYNTHESIS OF PROTEINS BY NATIVE CHEMICAL LIGATION [J].
DAWSON, PE ;
MUIR, TW ;
CLARKLEWIS, I ;
KENT, SBH .
SCIENCE, 1994, 266 (5186) :776-779
[7]   Solid-phase synthesis of peptide and glycopeptide thioesters through side-chain-anchoring strategies [J].
Ficht, Simon ;
Payne, Richard J. ;
Guy, Richard T. ;
Wong, Chi-Huey .
CHEMISTRY-A EUROPEAN JOURNAL, 2008, 14 (12) :3620-3629
[8]   Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy [J].
Gupta, Nancy ;
Vedi, Satish ;
Kunimoto, Dennis Y. ;
Agrawal, Babita ;
Kumar, Rakesh .
VACCINE, 2016, 34 (46) :5677-5688
[9]   Solid-phase synthesis of peptide selenoesters via a side-chain anchoring strategy [J].
Hanna, Cameron C. ;
Kulkarni, Sameer S. ;
Watson, Emma E. ;
Premdjee, Bhavesh ;
Payne, Richard J. .
CHEMICAL COMMUNICATIONS, 2017, 53 (39) :5424-5427
[10]   Activation of toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β defensin-2 [J].
Hertz, CJ ;
Wu, Q ;
Porter, EM ;
Zhang, YJ ;
Weismüller, KH ;
Godowski, PJ ;
Ganz, T ;
Randell, SH ;
Modlin, RL .
JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6820-6826